Year |
Citation |
Score |
2024 |
Huang F, Li K, Chen Z, Cui Z, Hankey W, Fang K, Yan J, Wang H, Jin VX, Dong Y, Wang Q. Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancer. Oncogene. PMID 39613933 DOI: 10.1038/s41388-024-03239-2 |
0.469 |
|
2024 |
Pornour M, Jeon HY, Ryu H, Khadka S, Xu R, Chen H, Hussain A, Lam HM, Zhuang Z, Oo HZ, Gleave M, Dong X, Wang Q, Barbieri C, Qi J. USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity. Proceedings of the National Academy of Sciences of the United States of America. 121: e2403331121. PMID 39052835 DOI: 10.1073/pnas.2403331121 |
0.462 |
|
2023 |
Chen L, Zhang Z, Han Q, Maity BK, Rodrigues L, Zboril E, Adhikari R, Ko SH, Li X, Yoshida SR, Xue P, Smith E, Xu K, Wang Q, Huang TH, et al. Hormone-induced enhancer assembly requires an optimal level of hormone receptor multivalent interactions. Molecular Cell. PMID 37738977 DOI: 10.1016/j.molcel.2023.08.027 |
0.404 |
|
2023 |
Wang ME, Chen J, Lu Y, Bawcom AR, Wu J, Ou J, Asara JM, Armstrong AJ, Wang Q, Li L, Wang Y, Huang J, Chen M. RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis. The Journal of Clinical Investigation. PMID 36928314 DOI: 10.1172/JCI166647 |
0.371 |
|
2023 |
Jeon HY, Pornour M, Ryu H, Khadka S, Xu R, Jang J, Li D, Chen H, Hussain A, Fazli L, Gleave M, Dong X, Huang F, Wang Q, Barbieri C, et al. SMAD3 promotes expression and activity of the androgen receptor in prostate cancer. Nucleic Acids Research. PMID 36727462 DOI: 10.1093/nar/gkad043 |
0.507 |
|
2022 |
Li T, Liu Q, Chen Z, Fang K, Huang F, Fu X, Wang Q, Jin VX. Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model. Nature Communications. 13: 3145. PMID 35672415 DOI: 10.1038/s41467-022-30960-x |
0.347 |
|
2021 |
Xu L, Yin Y, Li Y, Chen X, Chang Y, Zhang H, Liu J, Beasley J, McCaw P, Zhang H, Young S, Groth J, Wang Q, Locasale JW, Gao X, et al. A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33753479 DOI: 10.1073/pnas.2012748118 |
0.384 |
|
2021 |
Yuan F, Hankey W, Wagner EJ, Li W, Wang Q. Alternative polyadenylation of mRNA and its role in cancer. Genes & Diseases. 8: 61-72. PMID 33569514 DOI: 10.1016/J.Gendis.2019.10.011 |
0.393 |
|
2020 |
Hankey W, Sunkel B, Yuan F, He H, Thomas-Ahner JM, Chen Z, Clinton SK, Huang J, Wang Q. Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range. Translational Oncology. 13: 100797. PMID 32454444 DOI: 10.1016/J.Tranon.2020.100797 |
0.482 |
|
2020 |
Hankey W, Chen Z, Wang Q. Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors. Cancer Research. PMID 32094298 DOI: 10.1158/0008-5472.Can-19-3447 |
0.558 |
|
2019 |
Li Y, He Y, Butler W, Xu L, Chang Y, Lei K, Zhang H, Zhou Y, Gao AC, Zhang Q, Taylor DG, Cheng D, Farber-Katz S, Karam R, Landrith T, ... ... Wang Q, et al. Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. Science Translational Medicine. 11. PMID 31801883 DOI: 10.1126/Scitranslmed.Aax0428 |
0.508 |
|
2019 |
Yuan F, Hankey W, Wu D, Wang H, Somarelli J, Armstrong AJ, Huang J, Chen Z, Wang Q. Molecular determinants for enzalutamide-induced transcription in prostate cancer. Nucleic Acids Research. PMID 31501863 DOI: 10.1093/Nar/Gkz790 |
0.585 |
|
2018 |
Hankey W, Chen Z, Bergman MJ, Fernandez MO, Hancioglu B, Lan X, Jegga AG, Zhang J, Jin VX, Aronow BJ, Wang Q, Groden J. Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1. Oncotarget. 9: 31214-31230. PMID 30131849 DOI: 10.18632/Oncotarget.25781 |
0.43 |
|
2018 |
Lee YY, Mok MTS, Kang W, Yang W, Tang W, Wu F, Xu L, Yan M, Yu Z, Lee SD, Tong JHM, Cheung YS, Lai PBS, Yu DY, Wang Q, et al. Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis. Nucleic Acids Research. PMID 29992318 DOI: 10.1093/Nar/Gky589 |
0.315 |
|
2018 |
Chen Z, Wu D, Thomas-Ahner JM, Lu C, Zhao P, Zhang Q, Geraghty C, Yan PS, Hankey W, Sunkel B, Cheng X, Antonarakis ES, Wang QE, Liu Z, Huang TH, ... ... Wang Q, et al. Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13. Proceedings of the National Academy of Sciences of the United States of America. PMID 29844167 DOI: 10.1073/Pnas.1718811115 |
0.525 |
|
2017 |
Horning AM, Wang Y, Lin CK, Louie AD, Jadhav RR, Hung CN, Wang CM, Lin CL, Kirma NB, Liss MA, Kumar AP, Sun L, Liu Z, Chao WT, Wang Q, et al. Single-cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell cycle-related transcription and attenuated androgen response. Cancer Research. PMID 29233929 DOI: 10.1158/0008-5472.Can-17-1924 |
0.549 |
|
2017 |
Sunkel B, Wu D, Chen Z, Wang CM, Liu X, Ye Z, Horning AM, Liu J, Mahalingam D, Lopez-Nicora H, Lin CL, Goodfellow PJ, Clinton SK, Jin VX, Chen CL, ... ... Wang Q, et al. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence. Nucleic Acids Research. PMID 28419278 DOI: 10.1093/nar/gkx282 |
0.407 |
|
2016 |
McNair C, Urbanucci A, Comstock CE, Augello MA, Goodwin JF, Launchbury R, Zhao SG, Schiewer MJ, Ertel A, Karnes J, Davicioni E, Wang L, Wang Q, Mills IG, Feng FY, et al. Cell cycle-coupled expansion of AR activity promotes cancer progression. Oncogene. PMID 27669432 DOI: 10.1038/Onc.2016.334 |
0.521 |
|
2016 |
Ye Z, Chen Z, Sunkel B, Frietze S, Huang TH, Wang Q, Jin VX. Genome-wide analysis reveals positional-nucleosome-oriented binding pattern of pioneer factor FOXA1. Nucleic Acids Research. PMID 27458208 DOI: 10.1093/Nar/Gkw659 |
0.397 |
|
2016 |
Tang X, Liu H, Srivastava A, Pécot T, Chen Z, Wang Q, Huang K, Sáenz-Robles MT, Cantalupo P, Pipas J, Leone G. Transcriptome regulation and chromatin occupancy by E2F3 and MYC in mice. Scientific Data. 3: 160008. PMID 26881867 DOI: 10.1038/Sdata.2016.8 |
0.412 |
|
2016 |
Sunkel B, Wu D, Chen Z, Wang CM, Liu X, Ye Z, Horning AM, Liu J, Mahalingam D, Lopez-Nicora H, Lin CL, Goodfellow PJ, Clinton SK, Jin VX, Chen CL, ... ... Wang Q, et al. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence. Nucleic Acids Research. PMID 26743006 DOI: 10.1093/Nar/Gkv1528 |
0.553 |
|
2015 |
Chen Z, Lan X, Wu D, Sunkel B, Ye Z, Huang J, Liu Z, Clinton SK, Jin VX, Wang Q. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer. Nature Communications. 6: 8323. PMID 26374485 DOI: 10.1038/Ncomms9323 |
0.45 |
|
2015 |
Chen K, Chen Z, Wu D, Zhang L, Lin X, Su J, Rodriguez B, Xi Y, Xia Z, Chen X, Shi X, Wang Q, Li W. Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes. Nature Genetics. PMID 26301496 DOI: 10.1038/Ng.3385 |
0.372 |
|
2015 |
Liu H, Tang X, Srivastava A, Pécot T, Daniel P, Hemmelgarn B, Reyes S, Fackler N, Bajwa A, Kladney R, Koivisto C, Chen Z, Wang Q, Huang K, Machiraju R, et al. Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles. Nature Cell Biology. PMID 26192440 DOI: 10.1038/Ncb3210 |
0.344 |
|
2015 |
He H, Li W, Liyanarachchi S, Srinivas M, Wang Y, Akagi K, Wang Y, Wu D, Wang Q, Jin V, Symer DE, Shen R, Phay J, Nagy R, de la Chapelle A. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer. Proceedings of the National Academy of Sciences of the United States of America. 112: 6128-33. PMID 25918370 DOI: 10.1073/Pnas.1506255112 |
0.333 |
|
2015 |
Chen Z, Lan X, Thomas-Ahner JM, Wu D, Liu X, Ye Z, Wang L, Sunkel B, Grenade C, Chen J, Zynger DL, Yan PS, Huang J, Nephew KP, Huang TH, ... ... Wang Q, et al. Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer. The Embo Journal. 34: 502-16. PMID 25535248 DOI: 10.15252/Embj.201490306 |
0.579 |
|
2015 |
McNair C, Goodwin J, Augello M, Urbanucci A, Schiewer M, Comstock C, Ertel A, Wang L, Wang Q, Mills I, Li W, Carroll J, Knudsen K. Abstract 1844: Genome wide analysis of AR-cell cycle interplay reveals novel functions in cancer Cancer Research. 75: 1844-1844. DOI: 10.1158/1538-7445.Am2015-1844 |
0.513 |
|
2014 |
Zhang M, Manchanda PK, Wu D, Wang Q, Kirschner LS. Knockdown of PRKAR1A, the gene responsible for Carney complex, interferes with differentiation in osteoblastic cells. Molecular Endocrinology (Baltimore, Md.). 28: 295-307. PMID 24506536 DOI: 10.1210/Me.2013-1152 |
0.453 |
|
2014 |
Wu D, Sunkel B, Chen Z, Liu X, Ye Z, Li Q, Grenade C, Ke J, Zhang C, Chen H, Nephew KP, Huang TH, Liu Z, Jin VX, Wang Q. Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer. Nucleic Acids Research. 42: 3607-22. PMID 24423874 DOI: 10.1093/Nar/Gkt1382 |
0.606 |
|
2014 |
Ye Z, Chen Z, Lan X, Hara S, Sunkel B, Huang TH, Elnitski L, Wang Q, Jin VX. Computational analysis reveals a correlation of exon-skipping events with splicing, transcription and epigenetic factors. Nucleic Acids Research. 42: 2856-69. PMID 24369421 DOI: 10.1093/Nar/Gkt1338 |
0.363 |
|
2014 |
Sunkel BD, Wu D, Liu X, Ye Z, Jin V, Wang Q. Abstract 1387: Convergent CREB1/FoxA1 transcriptional activity defines castration-resistant prostate cancer gene expression profile Cancer Research. 74: 1387-1387. DOI: 10.1158/1538-7445.Am2014-1387 |
0.56 |
|
2014 |
Sunkel B, Wang Q. Looking beyond Androgen Receptor Signaling in the Treatment of Advanced Prostate Cancer Advances in Andrology. 2014: 1-9. DOI: 10.1155/2014/748352 |
0.514 |
|
2013 |
Chen H, Ma J, Sunkel B, Luo A, Ding F, Li Y, He H, Zhang S, Xu C, Jin Q, Wang Q, Liu Z. S100A14: novel modulator of terminal differentiation in esophageal cancer. Molecular Cancer Research : McR. 11: 1542-53. PMID 24107296 DOI: 10.1158/1541-7786.Mcr-13-0317 |
0.415 |
|
2013 |
He H, Li W, Wu D, Nagy R, Liyanarachchi S, Akagi K, Jendrzejewski J, Jiao H, Hoag K, Wen B, Srinivas M, Waidyaratne G, Wang R, Wojcicka A, Lattimer IR, ... ... Wang Q, et al. Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance. Plos One. 8: e61920. PMID 23690926 DOI: 10.1371/Journal.Pone.0061920 |
0.326 |
|
2013 |
Cai C, Wang H, He HH, Chen S, He L, Ma F, Mucci L, Wang Q, Fiore C, Sowalsky AG, Loda M, Liu XS, Brown M, Balk SP, Yuan X. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer. The Journal of Clinical Investigation. 123: 1109-22. PMID 23426182 DOI: 10.1172/Jci66666 |
0.588 |
|
2012 |
Cui J, Germer K, Wu T, Wang J, Luo J, Wang SC, Wang Q, Zhang X. Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells. Cancer Research. 72: 5625-34. PMID 22964581 DOI: 10.1158/0008-5472.Can-12-1305 |
0.42 |
|
2012 |
Sunkel B, Wang Q. Mapping mutations in prostate cancer exomes. Asian Journal of Andrology. 14: 801-2. PMID 22842706 DOI: 10.1038/Aja.2012.75 |
0.404 |
|
2012 |
Lan X, Witt H, Katsumura K, Ye Z, Wang Q, Bresnick EH, Farnham PJ, Jin VX. Integration of Hi-C and ChIP-seq data reveals distinct types of chromatin linkages. Nucleic Acids Research. 40: 7690-704. PMID 22675074 DOI: 10.1093/Nar/Gks501 |
0.382 |
|
2012 |
Taslim C, Chen Z, Huang K, Huang TH, Wang Q, Lin S. Integrated analysis identifies a class of androgen-responsive genes regulated by short combinatorial long-range mechanism facilitated by CTCF. Nucleic Acids Research. 40: 4754-64. PMID 22344698 DOI: 10.1093/Nar/Gks139 |
0.557 |
|
2012 |
Zhao JC, Yu J, Runkle C, Wu L, Hu M, Wu D, Liu JS, Wang Q, Qin ZS, Yu J. Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Research. 22: 322-31. PMID 22179855 DOI: 10.1101/Gr.131508.111 |
0.601 |
|
2011 |
Zhang C, Wang L, Wu D, Chen H, Chen Z, Thomas-Ahner JM, Zynger DL, Eeckhoute J, Yu J, Luo J, Brown M, Clinton SK, Nephew KP, Huang TH, Li W, ... Wang Q, et al. Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer. Cancer Research. 71: 6738-48. PMID 21900400 DOI: 10.1158/0008-5472.Can-11-1882 |
0.525 |
|
2011 |
Wu D, Zhang C, Shen Y, Nephew KP, Wang Q. Androgen receptor-driven chromatin looping in prostate cancer. Trends in Endocrinology and Metabolism: Tem. 22: 474-80. PMID 21889355 DOI: 10.1016/J.Tem.2011.07.006 |
0.576 |
|
2011 |
Wang H, Zhang C, Rorick A, Wu D, Chiu M, Thomas-Ahner J, Chen Z, Chen H, Clinton SK, Chan KK, Wang Q. CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability. Cancer Research. 71: 4866-76. PMID 21593191 DOI: 10.1158/0008-5472.Can-10-4576 |
0.484 |
|
2011 |
Chen Z, Zhang C, Wu D, Chen H, Rorick A, Zhang X, Wang Q. Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. The Embo Journal. 30: 2405-19. PMID 21556051 DOI: 10.1038/Emboj.2011.154 |
0.538 |
|
2011 |
Chen CH, Huang PH, Chu PC, Chen MC, Chou CC, Wang D, Kulp SK, Teng CM, Wang Q, Chen CS. Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression. The Journal of Biological Chemistry. 286: 9968-76. PMID 21282102 DOI: 10.1074/Jbc.M110.203240 |
0.487 |
|
2011 |
Frigo DE, Howe MK, Wittmann BM, Brunner AM, Cushman I, Wang Q, Brown M, Means AR, McDonnell DP. CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells. Cancer Research. 71: 528-37. PMID 21098087 DOI: 10.1158/0008-5472.Can-10-2581 |
0.505 |
|
2010 |
Chen Z, Wang L, Wang Q, Li W. Histone modifications and chromatin organization in prostate cancer. Epigenomics. 2: 551-60. PMID 21318127 DOI: 10.2217/Epi.10.31 |
0.528 |
|
2010 |
Hsu PY, Hsu HK, Singer GA, Yan PS, Rodriguez BA, Liu JC, Weng YI, Deatherage DE, Chen Z, Pereira JS, Lopez R, Russo J, Wang Q, Lamartiniere CA, Nephew KP, et al. Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Research. 20: 733-44. PMID 20442245 DOI: 10.1101/Gr.101923.109 |
0.414 |
|
2010 |
He HH, Meyer CA, Shin H, Bailey ST, Wei G, Wang Q, Zhang Y, Xu K, Ni M, Lupien M, Mieczkowski P, Lieb JD, Zhao K, Brown M, Liu XS. Nucleosome dynamics define transcriptional enhancers. Nature Genetics. 42: 343-7. PMID 20208536 DOI: 10.1038/Ng.545 |
0.548 |
|
2009 |
Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell. 138: 245-56. PMID 19632176 DOI: 10.1016/J.Cell.2009.04.056 |
0.609 |
|
2009 |
Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, Joseph JD, Toner AP, Brown M, McDonnell DP. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Molecular Endocrinology (Baltimore, Md.). 23: 1385-96. PMID 19460858 DOI: 10.1210/Me.2009-0010 |
0.549 |
|
2009 |
Sun T, Wang Q, Balk S, Brown M, Lee GS, Kantoff P. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Research. 69: 3356-63. PMID 19351832 DOI: 10.1158/0008-5472.Can-08-4112 |
0.36 |
|
2009 |
Nwachukwu JC, Mita P, Ruoff R, Ha S, Wang Q, Huang SJ, Taneja SS, Brown M, Gerald WL, Garabedian MJ, Logan SK. Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. Cancer Research. 69: 3140-7. PMID 19318562 DOI: 10.1158/0008-5472.CAN-08-3738 |
0.533 |
|
2009 |
Wang QJ, Wu G, Mi S, He F, Dong J, Mattison RJ, Kaberlein J, Wang Q, Prabhakar S, Ji H, Thirman MJ. MLL Fusion Proteins Directly Regulate a Small Set of Wild Type MLL Target Genes. Blood. 114: 1279-1279. DOI: 10.1182/Blood.V114.22.1279.1279 |
0.415 |
|
2008 |
Agoulnik IU, Bingman WE, Nakka M, Li W, Wang Q, Liu XS, Brown M, Weigel NL. Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase. Molecular Endocrinology (Baltimore, Md.). 22: 2420-32. PMID 18787043 DOI: 10.1210/Me.2007-0481 |
0.548 |
|
2008 |
Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell. 132: 958-70. PMID 18358809 DOI: 10.1016/J.Cell.2008.01.018 |
0.416 |
|
2008 |
Bao BY, Chuang BF, Wang Q, Sartor O, Balk SP, Brown M, Kantoff PW, Lee GS. Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. The Prostate. 68: 839-48. PMID 18302198 DOI: 10.1002/Pros.20749 |
0.5 |
|
2008 |
Wang Q, Dong J, Mattison R, Prabhakar S, Arimura FE, Kaberlein J, Wang C, Wang Q, Nobrega M, Thirman M. Autoregulation of MEIS1 through a Distal Enhancer in Acute Leukemia Blood. 112: 745-745. DOI: 10.1182/Blood.V112.11.745.745 |
0.459 |
|
2007 |
Wang Q, Li W, Liu XS, Carroll JS, Jänne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Molecular Cell. 27: 380-92. PMID 17679089 DOI: 10.1016/J.Molcel.2007.05.041 |
0.6 |
|
2006 |
Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, et al. Genome-wide analysis of estrogen receptor binding sites. Nature Genetics. 38: 1289-97. PMID 17013392 DOI: 10.1038/Ng1901 |
0.468 |
|
2006 |
Wang QF, Prabhakar S, Wang Q, Moses AM, Chanan S, Brown M, Eisen MB, Cheng JF, Rubin EM, Boffelli D. Primate-specific evolution of an LDLR enhancer. Genome Biology. 7: R68. PMID 16884525 DOI: 10.1186/Gb-2006-7-8-R68 |
0.31 |
|
2005 |
Wang Q, Carroll JS, Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Molecular Cell. 19: 631-42. PMID 16137620 DOI: 10.1016/J.Molcel.2005.07.018 |
0.55 |
|
2004 |
Wang Q, Udayakumar TS, Vasaitis TS, Brodie AM, Fondell JD. Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells. The Journal of Biological Chemistry. 279: 17319-28. PMID 14966121 DOI: 10.1074/Jbc.M400970200 |
0.734 |
|
2003 |
Wang H, Wang Q, Srivastava RK, Gong SS, Lao L, Fondell JD, Wang JB. Effects of total glycosides from Baishouwu on human breast and prostate cancer cell proliferation. Alternative Therapies in Health and Medicine. 9: 62-6. PMID 14526712 |
0.661 |
|
2002 |
Wang Q, Sharma D, Ren Y, Fondell JD. A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. The Journal of Biological Chemistry. 277: 42852-8. PMID 12218053 DOI: 10.1074/Jbc.M206061200 |
0.743 |
|
2002 |
Zhang Y, Fondell JD, Wang Q, Xia X, Cheng A, Lu ML, Hamburger AW. Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1. Oncogene. 21: 5609-18. PMID 12165860 DOI: 10.1038/Sj.Onc.1205638 |
0.743 |
|
2001 |
Wang Q, Fondell JD. Generation of a mammalian cell line stably expressing a tetracycline-regulated epitope-tagged human androgen receptor: implications for steroid hormone receptor research. Analytical Biochemistry. 289: 217-30. PMID 11161315 DOI: 10.1006/Abio.2000.4960 |
0.721 |
|
2000 |
Ren Y, Behre E, Ren Z, Zhang J, Wang Q, Fondell JD. Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors. Molecular and Cellular Biology. 20: 5433-46. PMID 10891484 DOI: 10.1128/Mcb.20.15.5433-5446.2000 |
0.681 |
|
Show low-probability matches. |